Tube Investments of India Ltd
Tube Investments of India Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management said on revenue, margins and capex.
Tube Investments of India Ltd Q2 FY26 key numbers
- Revenue
- Capex of Rs. 300-400 Crores planned for base business expansion.
As stated in Tube Investments of India Ltd's Q2 FY26 earnings call transcript · published 14 Jun 2026. Reported figures, not investment advice.
The short version
Core standalone business expected to grow revenues by ~10% with PBT growth of 12-15% in FY2026. Standalone business revenue growth expected around 10%; PBT growth projected between 12%-15%. - TI Medical targeted for 25% CAGR growth including new vertical additions. - Engineering division volume growth approx.
From Tube Investments of India Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Core standalone business expected to grow revenues by ~10% with PBT growth of 12-15% in FY2026.
- Capex of Rs. 300-400 Crores planned for base business expansion.
- Additional Rs. 300-400 Crores capex targeted for growth initiatives in TI Medical, 3xper, and related ventures.
- Rs. 200-300 Crores earmarked for potential M&A or new business lines to boost growth.
- TI Medical aims for a 25% CAGR growth, adding new verticals beyond sutures.
- EV segment: 50%+ market share in electric trucks pan-India with product launches including swap technology and new variants to drive volume growth.
- Three-wheeler EV volumes expected to pick up from Q4 after product improvements.
2 more points from Tube Investments of India Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Tube Investments of India Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Next Year Capex Plans:
- Rs. 300-400 Crores for standalone (base) business expansion.
- Rs. 300-400 Crores planned for growth areas including TI Medical (Greenfield) and 3xper Innoventure.
- Additional Rs. 200-300 Crores may be allocated for M&A activities in related new lines of business.
- Investment in TI Clean Mobility to be decided later in the year.
- 3xper Innoventure:
- Total planned investment of Rs. 300 Crores.
- Rs. 200 Crores invested till last year.
- Rs. 50 Crores invested this year (Q1 and Q2).
- Remaining Rs. 50 Crores to be deployed this year.
- TI Medical:
- Investments focused on new medical lines beyond sutures.
- Growth driven by operational and capital investments.
- Strategic Focus:
2 more points from Tube Investments of India Ltd's call on capex
Create a free account to keep reading this call
Fundraising & Capital Structure
See what Tube Investments of India Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Engineering division is running at 80% to 85% capacity utilization, with new plants at Nasik and Phaltan starting operations recently, providing capacity for the next 1-2 years.
- Railway business has a strong order book with expected revenue growth starting Q4 FY2026, though there is a one-quarter delay due to other suppliers’ supply chain readiness; TI’s readiness is confirmed.
- TI Clean Mobility's electric vehicle segment has existing orders with 300+ trucks already running, and new product launches planned, indicating a healthy order pipeline.
- Medical devices and 3xper have ongoing investments with planned capex and expected growth, indicating committed orderbook and work-in-progress.
Tube Investments of India Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹6.2K Cr, net profit ₹234 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Tube Investments's management said in earlier quarters
Others in Auto Components this season
- Tenneco Clean Air India Ltd (Q2 FY26)
Growth in Clean Air and Powertrain Solutions segment was 3% YoY in the recent quarter, slightly underperforming industry growth; however, this is seen as a…
- Divgi Torq (Q2 FY26)
Current orders under execution are valued at approximately INR 90 crore, derived from contractual prices and RFQ volumes from Tier 1 customers. Key concall…
- Autoline Industries Ltd (Q2 FY26)
Revenue for Q2 FY26: INR 172.79 crore, up 10.78% year-on-year. Key investor presentation takeaways from Autoline Industr's Q2 FY26 investor presentation — and h
- Carraro India (Q2 FY26)
. Key concall takeaways from Carraro India Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Tube Investments of India Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Tube Investments of India Ltd Q2 FY26 results?
Core standalone business expected to grow revenues by ~10% with PBT growth of 12-15% in FY2026. Standalone business revenue growth expected around 10%; PBT growth projected between 12%-15%. - TI Medical targeted for 25% CAGR growth including new vertical additions. - Engineering division volume growth approx.
What is Tube Investments of India Ltd share price analysis?
Tube Investments of India Ltd currently shows a neutral. The stock trades at a P/E of 84.4 with a market cap of ₹52,913 Cr. Investors should review the full earnings analysis for detailed insights.
Is Tube Investments of India Ltd planning capital expenditure?
Next Year Capex Plans: - Rs.
Keep Tube Investments of India Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.